Table 2.
The main Characteristics of PCa patients included for survival analysis
| Number of patients (N) | 69 |
| Duration of follow up time (mean, SD) | 64.9 ± 25.84 |
| Duration of follow up time (median) | 60 months |
| Number of BCR (%) | 25 (36.3%) |
| Number of metastasis patients (%) | 4 (5.7%) |
| Number of alive patients without any complication (%) | 43 (62.3%) |
| Number of deaths related to PCa (%) | 22 (31.8%) |
OS overall survival; DSS disease-specific survival; BCR biochemical recurrence